Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02702765Completed
Open-label, single-arm trial, sponsored by Aarhus University. Primary endpoints: Soluble CD163 at 3 years and Soluble Mannose Receptor at 3 years. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02702765.